You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Brawn Biotech Ltd"

Brawn Biotech Ltd Revised Annual Audited Financial Results In Accordance With Schedule III Format Of Companies Act 201

  • 21/07/2017
  • |
  • bse

Brawn Biotech Ltd Statement Of Investor Complaints For The Quarter Ended On 30Th June 2017

  • 12/07/2017
  • |
  • bse

Brawn Biotech Ltd Change In Registered Address Of Brawn Biotech Limited

  • 03/07/2017
  • |
  • bse

Brawn Biotech Ltd Change in Directorate

  • 03/07/2017
  • |
  • bse

Brawn Biotech Ltd Board recommends Final Dividend

  • 30/05/2017
  • |
  • bse

Brawn Biotech Ltd Audited Financial Results For The Quarter And Year Ended March 31 2017

  • 29/05/2017
  • |
  • bse

Brawn Biotech Ltd Intimation Of 2Nd/ 2017-18 Board Meeting & Trading Window Closure Notice

  • 23/05/2017
  • |
  • bse

Brawn Biotech Ltd Intimation Of Board Meeting & Trading Window Closure Notice

  • 22/05/2017
  • |
  • bse

Brawn Biotech Ltd Compliance Certificate For The Period Ended 31St March 2017

  • 21/04/2017
  • |
  • bse

Brawn Biotech Ltd Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligation

  • 18/04/2017
  • |
  • bse

Brawn Biotech Ltd Statement On Investors Complaints For Quarter Ended On 31St March 2017

  • 15/04/2017
  • |
  • bse

Brawn Biotech Ltd Change in Directorate

  • 12/04/2017
  • |
  • bse

Brawn Biotech Ltd Outcome of Board Meeting

  • 12/04/2017
  • |
  • bse

Brawn Biotech Ltd Board Meeting On Wednesday 12Th April 2017

  • 04/04/2017
  • |
  • bse

Brawn Biotech Ltd Outcome of Board Meeting

  • 22/02/2017
  • |
  • bse

Brawn Biotech Ltd Limited Review Report for December 31 2016

  • 07/02/2017
  • |
  • bse

Brawn Biotech Ltd Standalone Financial Results for December 31 2016

  • 07/02/2017
  • |
  • bse

Brawn Biotech Ltd Board Meeting Intimation for Results & Closure of Trading Window

  • 30/01/2017
  • |
  • bse

Brawn Biotech Ltd Resignation of Company Secretary & Compliance Officer

  • 09/01/2017
  • |
  • bse

Brawn Biotech Ltd Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended D

  • 07/01/2017
  • |
  • bse